Effects of encainide and metabolizer phenotype on ventricular conduction during exercise.
Karalis
D G
DG
Likoff Cardiovascular Institute, Department of Medicine, Hahnemann University, Philadelphia, Pennsylvania 19102-1192.
Nydegger
C
C
Porter
R S
RS
Carver
J
J
Pina
I L
IL
Kutalek
S P
SP
Michelson
E L
EL
D000328:Adult; D000368:Aged; D000813:Anilides / Q000097:blood / Q000627:therapeutic use*; D000889:Anti-Arrhythmia Agents / Q000097:blood / Q000627:therapeutic use*; D001145:Arrhythmias, Cardiac / Q000188:drug therapy*; D015716:Electrocardiography, Ambulatory; D016700:Encainide; D005260:Female; D006329:Heart Conduction System / Q000187:drug effects*; D006801:Humans; D008297:Male; D008838:Microcomputers; D008875:Middle Aged; D010641:Phenotype; D005082:Physical Exertion
D000813:Anilides; D000889:Anti-Arrhythmia Agents; D016700:Encainide